Literature DB >> 10800484

Monoclonal antibodies, cytokines and fusion proteins in the treatment of malignant disease.

J A Hank1, M R Albertini, P M Sondel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10800484

Source DB:  PubMed          Journal:  Cancer Chemother Biol Response Modif        ISSN: 0921-4410


× No keyword cloud information.
  2 in total

1.  Anti-GD2 Strategy in the Treatment of Neuroblastoma.

Authors:  Richard K Yang; Paul M Sondel
Journal:  Drugs Future       Date:  2010       Impact factor: 0.148

Review 2.  The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma.

Authors:  Brett H Yamane; Jacquelyn A Hank; Mark R Albertini; Paul M Sondel
Journal:  Expert Opin Investig Drugs       Date:  2009-07       Impact factor: 6.206

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.